Funds and ETFs Shin Nippon Biomedical Laboratories, Ltd.

Equities

2395

JP3379950003

Biotechnology & Medical Research

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
1,502 JPY +1.49% Intraday chart for Shin Nippon Biomedical Laboratories, Ltd. +5.55% -11.54%

ETFs positioned on Shin Nippon Biomedical Laboratories, Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.51% 23 M€ +1.75% -
0.08% 19 M€ +3.83%
0.01% 18 M€ +16.15% -
0.01% 144,586 M€ +14.49%
0.01% 66,066 M€ +14.68% -
0.01% 20,721 M€ +13.52% -
0.00% 10 M€ -3.35% -
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test articles on human. The Translational Research segment is involved in the research and development of pharmaceutical products and related technology, as well as the conduction of preclinical and clinical trials, among others. The Others segment is engaged in information collecting business, the sale of environmental analysis equipment, and the operation of accommodation. As of March 31, 2013, the Company had 27 subsidiaries and one associated company.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,502 JPY
Average target price
3,150 JPY
Spread / Average Target
+109.72%
Consensus
  1. Stock Market
  2. Equities
  3. 2395 Stock
  4. Funds and ETFs Shin Nippon Biomedical Laboratories, Ltd.